A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study

NCT06801379 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Inhaled Melatonin (100 μg)
DRUG: Oral Melatonin (4 mg)

Sponsor

Woolcock Institute of Medical Research